Akigai Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Employees
  • 9

Employees

  • Latest Deal Type
  • Early Stage VC

  • Investors
  • 1

Akigai General Information

Description

Developer of a drug development company designed to produce treatments for neuropathic pain. The company maps and markets EGFR inhibitors and development candidates tested in clinical trials, and aims to collaborate with owners to bring an inhibitor to the neuropathic pain market, enabling patients to find relief from chronic pain.

Contact Information

Website
www.akigai.no
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • C/o Stig Nordal
  • Hasselbakken 7
  • 0851 Oslo
  • Norway
Primary Industry
Drug Discovery
Corporate Office
  • C/o Stig Nordal
  • Hasselbakken 7
  • 0851 Oslo
  • Norway

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Akigai Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC 01-Jan-2023 Completed Pre-Clinical Trials
To view Akigai’s complete valuation and funding history, request access »

Akigai Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Akigai Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Startuplab Ventures Venture Capital Minority
To view Akigai’s complete investors history, request access »

Akigai FAQs

  • When was Akigai founded?

    Akigai was founded in 2022.

  • Where is Akigai headquartered?

    Akigai is headquartered in Oslo, Norway.

  • What is the size of Akigai?

    Akigai has 9 total employees.

  • What industry is Akigai in?

    Akigai’s primary industry is Drug Discovery.

  • Is Akigai a private or public company?

    Akigai is a Private company.

  • What is Akigai’s current revenue?

    The current revenue for Akigai is .

  • Who are Akigai’s investors?

    Startuplab Ventures has invested in Akigai.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process